Signature
Phillip D. Carrai, by Eva Yee, Attorney-In-Fact
Issuer symbol
KTOS
Transactions as of
17 Feb 2026
Net transactions value
-$590,913
Form type
4
Filing time
19 Feb 2026, 19:55:53 UTC
Previous filing
16 Jan 2026
Next filing
06 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carrai Phillip D President, STC Division 10680 TREENA STREET, SUITE 600, SAN DIEGO Phillip D. Carrai, by Eva Yee, Attorney-In-Fact 19 Feb 2026 0001509409

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTOS Common Stock Sale $43,874 -500 -0.23% $87.75 219,325 17 Feb 2026 Direct F1, F2, F6
transaction KTOS Common Stock Sale $116,423 -1,314 -0.6% $88.60 218,011 17 Feb 2026 Direct F1, F3, F6
transaction KTOS Common Stock Sale $8,948 -100 -0.05% $89.48 217,911 17 Feb 2026 Direct F1, F6
transaction KTOS Common Stock Sale $299,565 -3,267 -1.5% $91.69 214,644 17 Feb 2026 Direct F1, F4, F6
transaction KTOS Common Stock Sale $112,788 -1,219 -0.57% $92.52 213,425 17 Feb 2026 Direct F1, F5, F6
transaction KTOS Common Stock Sale $9,315 -100 -0.05% $93.15 213,325 17 Feb 2026 Direct F1, F6
holding KTOS Common Stock 46,644 17 Feb 2026 by trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 26, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.20 to $88.16 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.20 to $89.17 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.15 to $92.14 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.15 to $93.11 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F6 Includes 1,232 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 4,230 shares held through Issuer's 401(k) Plan.